...some freeing up of investment cash for companies that have gone through a few (or more than a few) rounds. Glucose monitoring system Signos raised a $20 million round. The investment is from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. Funding to date including this round is $57 million. Signos is also a partner with Dexcom through their direct-to-consumer continuous glucose monitoring website, Stelo.com. Signos’ app for tracking glucose for weight management is FDA-cleared and includes insights into how behavior, lifestyle, sleep, and stress affect weight. It can also detect low and high glucose levels. Membership... Continue Reading
Search Results for google
Selling Oracle Health’s EHR–what are the potential buyers, their odds, and price?
...is an established vendor in other areas of health systems, and acquiring an EHR could be seen as too much under one roof. Problem: no experience with EHRs (same as Oracle) nor highly regulated health systems. The scale of the MHS/VA implementation and academic hospitals would be a steep learning curve with little existing precedent or credibility in Amazon-World. Google certainly has the size and resources, and could position the EHR to rival both Microsoft and Epic. Conflict #1: Cultural. Google moves fast and healthcare slowly. Conflict #2: Lacks the enterprise sales and support needed to service health systems. It... Continue Reading
A Must-Read potpourri: the ‘math’ of AI data center builds, healthcare AI failures, telehealth in schools, Hippocratic AI’s problems, the loss of empathy.
...a horrifying situation where Oracle desperately needs OpenAI to pay it for capacity that doesn’t exist, and if it ever gets built, it’s likely to be years after OpenAI has run out of money, which is the same problem that Microsoft, Google, and Amazon have with their $748 billion of deals with Anthropic and OpenAI, though thanks to the $340 billion or more necessary to build the Stargate data centers, Oracle’s problems are far more existential.” The article also makes the point that Oracle does not have the fallback businesses that Microsoft, Google, and Amazon have to cushion the blow... Continue Reading
Chutes & Ladders: Ad trackers still on healthcare websites after lawsuits, FTC; the US Navy adds WHOOPs it up and expands Talkspace; HealthVerity to buy Symphony Health; Nervonik’s $52.5M Series B
...and ad targeting, sending PHI and PII to third parties for that purpose violates privacy. The other 30 states use the Federal Healthcare.gov insurance exchange site. California removed trackers in 2025. In 2022, ad trackers were on health system websites, large provider groups such as VillageMD, and e-prescribers such as the controversial Cerebral. Trackers such as Meta Pixel were disclosing all sorts of protected information that violated HIPAA and privacy guidelines to third parties such as Facebook, Instagram, and Google–and monetized. Most health systems removed them and Cerebral was fined for this as well as other issues. TTA 16 April... Continue Reading
A quickie news roundup: ChatGPT for Clinicians unveiled, UHG to invest $1.5B in AI, Aidoc raises $150M, TriFetch raises $1.9M pre-seed, Boehringer Ingelheim & Eko Health partner on canine heart murmur detection
...led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors and NVentures (NVIDIA’s venture capital arm). The fresh funds will be used to grow global presence and expand into other clinical areas. FDA clearance for its AI triage tool was gained in January. Mobihealthnews, Release TriFetch has a healthy pre-seed round. A $1.9 million pre-seed these days is rather unusual but TriFetch, an AI automation platform built for independent specialty clinics just emerging from stealth, nabbed it from Nexus Venture Partners, with participation from angels with backgrounds at Google, Hippocratic, Mercor, and MIT. TriFetch’s... Continue Reading
Even famous doctors have their identity stolen: Dr. Eric Topol “authors” an apparently fake, AI-generated paper
...site can’t be reached”), but also trying to reach the e-PubMed.co.uk site by entering it directly goes to the same screen. When I searched under Ellinger Publishing in Google and the same URL came to the top under them [see screenshot right below], the link equally does not work. The UK E-PubMed Central is now Europe PMC concentrating on UK/EU research and partners with the US NIH PubMed site on certain papers, from what I have read online. Gemini came up with this about Ellinger: “Ellinger Publishing Media: An independent academic publisher specializing in open-access journals, specifically focusing on artificial... Continue Reading
Chutes & Ladders: Vendor protest filed against VA-OIT, Teladoc stock touted as ‘best buy’, Treehub ‘founder residency’ launches, AcuityMD raises $80M to near-$1B valuation
...studio with hands-on support, and an incubator community, with the capital of a venture fund. The Los Altos-based residency program is funded via the AI Health Fund and has some heavyweight names attached to it: Mary Minno, herself a former venture-backed founder now at Google, a brace of Stanford professors, Derek Minno of Point Capital, and two Wojcickis: Anne Wojcicki, founder of 23andMe, as Operating Partner and her mother, Esther Wojcicki, as a Founding Advisor. One wonders how Anne Wojcicki is faring in rebuilding 23andMe’s business and the 23andMe Research Institute; certainly they haven’t been shy about new products such... Continue Reading
‘AI doctor’ Doctronic raises $40M Series B, but faces controversy on autonomous Rx renewals in Utah and effectiveness claims
...in 2026. The basic health tech sounds not that unusual: a chatbot discusses your medical concerns and questions, much like a Claude for Healthcare, Microsoft Copilot Health, Teladoc, Ro, or even Google Gemini. The next step is a clinician referral, available 24/7 in all 50 states, for a low $39. It also claims to securely retain your information and timeline/meds/labs, not using the data for AI training. Where the controversy centers is Doctronic’s first-ever state-approved autonomous AI test with the state of Utah. Announced in January, it will test whether a chatbot agent can evaluate and renew existing prescriptions for... Continue Reading
News roundup: Microsoft debuts a rebooted Copilot Health, Stryker whacked by Iranian cyberattack, Amazon buys Rivr robotics for delivery, Turquoise Health’s $40M raise, Verily raises $300M to shake off Alphabet control
...Partners, and Yosemite, for a total raise of $100 million. Release, MedCityNews And winding up the week, Verily raises $300 million–and independence from Alphabet. Now rebranded as Verily Health Inc., it is now a precision health solutions company. It has pivoted since at least 2016 from various iterations as originally the Google X life sciences ‘skunkworks’–devices, bioelectronics, smart contact lenses, smartwatches, smart diapers… The funding was led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz and other investors. Alphabet remains a significant minority investor in Verily, while no longer having a controlling stake. Release... Continue Reading
Oracle’s rock-and-hard place in Abilene TX: building out a data center with Nvidia chips that are already obsolete–and the financing it takes (updated)
...line AI companies like OpenAI (or Anthropic for that matter) want the latest, because that is critical to their business. Another ‘rock’ that Oracle has is that the datacenters are being financed via at least $100 billion in debt. Google, Amazon, Meta, and Microsoft are able to finance datacenter builds via their cash-generating businesses, even if this hyperscaling means that the cash cows become somewhat starved for feed. Oracle has to advance money in construction and equipment it must raise in debt markets for a return that may come in a year, two, or even more. [TTA 5 Feb] In... Continue Reading
Most Recent Comments